Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation.
Lars Jøran KjerpesethHanne EllekjærRandi SelmerInger AriansenKari FuruEva SkovlundPublished in: European journal of clinical pharmacology (2018)
The uptake of DOACs was rapid and spurred an increase in new users of oral anticoagulants for atrial fibrillation from 2010 to 2015 in Norway. The mean CHA2DS2-VASc score did not change substantially during this period. Vascular disease, heart failure, and diabetes were associated with initiation of warfarin, and previous stroke, age 65-74 and female sex with initiation of DOACs.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- direct oral anticoagulants
- heart failure
- catheter ablation
- left atrial
- left atrial appendage
- type diabetes
- cardiovascular disease
- percutaneous coronary intervention
- coronary artery disease
- skeletal muscle
- decision making
- loop mediated isothermal amplification
- cardiac resynchronization therapy
- insulin resistance